Which continuous glucose monitoring (CGM) systems are the most accurate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Most Accurate CGM Systems

Based on the most recent head-to-head comparison study, the FreeStyle Libre 3 demonstrates superior accuracy over the Dexcom G7, with a significantly lower mean absolute relative difference (MARD) of 8.9% versus 13.6% (P < 0.0001). 1

Current Accuracy Rankings

The 2024 direct comparison study provides the strongest evidence for accuracy differentiation between the two dominant CGM platforms currently in widespread use:

FreeStyle Libre 3 (Abbott)

  • MARD: 8.9% with 91.4% of glucose values within ±20 mg/dL/±20% of reference 1
  • Maintains superior accuracy throughout the entire wear period, particularly after the first 12 hours (10.0% vs 15.1% MARD) 1
  • More accurate across all glucose ranges evaluated 1

Dexcom G7

  • MARD: 13.6% with 78.6% of glucose values within ±20 mg/dL/±20% of reference 1
  • Similar accuracy to FreeStyle Libre 3 only during the first 12 hours of wear 1

Emerging Technology

A novel uCGM 100 system (15.5-day wear) demonstrated exceptional accuracy with MARD of 7.6% and 95.5% agreement rate in a 2026 study, though this requires validation in broader populations 2

Historical Context and Older Systems

Previous generation comparisons show:

  • Dexcom G4 Platinum: MARD 12.2% (home use) and 13.6% (clinical setting) 3
  • Medtronic Enlite: MARD 19.9% (home use) and 16.6% (clinical setting) - consistently less accurate than Dexcom 3
  • FreeStyle Navigator: MARD 12.1% overall in older studies 4

Critical Accuracy Considerations

Hypoglycemia Detection

All CGM systems demonstrate reduced accuracy in the hypoglycemic range (<70 mg/dL), which is clinically significant:

  • FreeStyle Libre 3 and Dexcom G7 both show higher MARD during hypoglycemia 1
  • Historical data shows hypoglycemic MARD of 17.6% (Dexcom G4) versus 24.6% (Medtronic Enlite) 3
  • This represents a critical safety consideration when choosing systems for patients with hypoglycemia risk 4

FDA Integration Standards

Both Dexcom G7 and FreeStyle Libre 2 Plus are FDA-approved as integrated CGM (iCGM) for use with automated insulin delivery systems, meeting higher regulatory accuracy standards 5. The FreeStyle Libre 3, while more accurate in research studies, should be verified for specific AID system compatibility.

Clinical Decision Algorithm

For patients prioritizing accuracy:

  1. First choice: FreeStyle Libre 3 - highest demonstrated accuracy in head-to-head comparison 1
  2. Second choice: Dexcom G7 - if AID system integration is required or patient preference 5

For patients requiring AID integration:

  • Verify FDA approval for specific AID system compatibility (both Dexcom G7 and FreeStyle Libre 2 Plus approved) 5

For patients with frequent hypoglycemia:

  • Consider that all systems have reduced accuracy in hypoglycemic range
  • Real-time alarms (rtCGM) may be preferable to intermittently scanned systems 5

Important Caveats

  • Interfering substances and temperature can affect all CGM accuracy - patient education is essential 5
  • Sensor calibration requirements vary by device; most modern systems are factory-calibrated 5
  • Skin reactions occur with all systems and must be monitored 5
  • Cost considerations: While accuracy is important, patients with type 2 diabetes rank out-of-pocket cost as equally or more important than accuracy 6

The accuracy advantage of FreeStyle Libre 3 is statistically significant and clinically meaningful, particularly given the 4.7% absolute difference in MARD and 12.8% difference in values meeting accuracy standards 1.

References

6
Research

Important Continuous Glucose Monitoring Attributes for Patients With Type 2 Diabetes.

Clinical diabetes : a publication of the American Diabetes Association, 2025

Related Questions

For a 90‑day supply, how many Dexcom continuous glucose monitoring sensors, transmitters, and receivers should be ordered?
What are the troubleshooting steps for a weak Dexcom (Continuous Glucose Monitoring System) G7 sensor signal?
How should I write a prescription for the FreeStyle Libre sensor device (continuous glucose monitoring)?
How often should someone replace the Dexcom (Continuous Glucose Monitoring System) G7 sensor?
Are all continuous glucose monitors (CGMs) the same?
What is the appropriate empiric therapy for a healthy young man with an acute, painful, red, warm swelling of the thigh without prior medical history or trauma?
How should a patient with diarrhea, amoebiasis (trophozoites positive) and Helicobacter pylori (H. pylori) positive gastritis be managed?
What are the recommended emergency management guidelines for status epilepticus?
What are the diagnostic criteria for familial Mediterranean fever?
What is the recommended management for a patient with an upper gastrointestinal bleed?
What diagnostic workup and initial treatment should be undertaken for a 24-year-old male with previously diagnosed iron deficiency anemia, incidental pallor, and no current symptoms?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.